Photo of Hubert Weinberg

Hubert Weinberg

  • CLINICAL PROFESSOR Surgery
Print ProfilePrint Profile

Certifications

  • American Board of Plastic Surgery

Education

  • MD, New York Presbyterian - Weill Cornell Medical Center

  • Residency, Surgery
    Mount Sinai Hospital

  • Residency, Surgery
    Mount Sinai Hospital

  • Residency, Plastic Surgery
    Mount Sinai Hospital

Biography

    Dr. Weinberg has been certified by The American Board of Plastic Surgery since 1982. He received his BA, summa cum laude, from Yeshiva University and received his medical degree from Cornell University. He completed his residency training at The Mount Sinai Hospital. He is a member of numerous societies including a Fellow of the American College of Surgeons, member of the American Society of Plastic Surgeons, American Association of Plastic Surgeons, American Society of Reconstructive Microsurgery, Plastic Surgery Research Council, American Society for Peripheral Nerve, New York Surgical Society, and New York Academy of Medicine. His name is listed in Marquis Who's Who in America and Who's Who in Science and Engineering. He was director of the Microsurgical Research Laboratory in the division of Plastic Surgery from 1982-2000 and has authored numerous articles in this particular field. His clinical interests include cosmetic and reconstructive surgery. He has a special interest in minimal scar cosmetic surgery as well as innovative approaches to the surgical treatment of neurofibromatosis.

Awards

  • 1997 -
    Scholarship Essay Contest, Investigator Category
    Plastic Surgery Educational Foundation

  • 1987, 1993, 1997 -
    First Prize, co-author
    New York Academy of Medicine

  • 1985 -
    Third Prize, co-author
    New York Academy of Medicine

  • 1983 -
    Scholarship Contest
    Plastic Surgery Educational Foundation

  • 1981 -
    AAS Bella Trachtenberg Award for House Staff Excellence

  • 1973 - 1975
    Irma T. Hirshl Scholarship

  • 1971 -
    Summa Cum Laude

  • 1971 - 1975
    New York State Regents Scholarship in Medicine

  • 1969 -
    Alpha Epsilon Delta National Premedical Honor Society

  • 1967 - 1971
    New York State Regents Scholarship and Incentive Award

Research

  • Plastic surgery repair
  • Reconstruction of deformities caused by neurofibromatosis

Publications

Hirigoyen MB, Prabhat A, Zhang WX, Weinberg H. Improved efficacy of urokinase further prolongs ischemic flap survival. J Reconstr Microsurg 1995; 11: 151.

Weinberg H. Plastic surgical treatment of patients with pseudoxanthoma elasticum. PXE Awareness 1995; 3: 4.

Hirigoyen MB, Zhang WX, Weinberg H. A standardized model of microvenous thrombosis. J Reconstr Microsurg 1995; 11: 455.

Hirigoyen MB, Zhang WX, Gordon RE, Prabhat A, Urken ML, Weinberg H. Additional benefits of heparin in the thrombolytic salvage of ischemic skin flaps. Ann Plast Surg 1995; 35: 612.

Hirigoyen MB, Zhang WX, Lin D, Weinberg H, Urken ML. Use of the guinea-pig flank flap in skin flap research. Otolaryngol Head & Neck Surg 1995; 112: 723.

Forman DL, Shah DK, Zhang WX, Senderoff DM, Israeli D, Urken ML, Weinberg H. Evaluation of a continuous systemic infusion of iloprost, a stable PGI-2 analog, on survival of experimental skin flaps. J Reconstr Microsurg 1995; 11: 339.

Hirigoyen MB, Rhee J, Weisz D, Zhang WX, Urken ML, Weinberg H. Reappraisal of the epigastric flap: a new neurovascular flap in the rat. Plast Reconstr Surg 1996; 98: 700.

Hirigoyen MB, Zhang WX, Weinberg H, Buchbinder D. Periadventitial delivery of heparin in the prevention of microvenous thrombosis. J Oral Maxillofacial Surg 1996; 54: 1097.

Weinberg H. Abdominal wall strength and stability following breast reconstruction with the TRAM flap. Curr Surg 1996; 53: 154.

Hirigoyen MB, Prabhat A, Zhang WX, Urken ML, Weinberg H. Thrombolysis at a controlled pressure prolongs the survival of skin flaps treated with superoxide dismutase. J Reconstr Microsurg 1996; 12: 195.

Choi M, Hirigoyen MB, Zhang W, Weinberg H, Silver L, Chun J. Increased patency of artificial microvascular grafts using arteriovenous fistula loops: a two-stage procedure for lengthening the pedicle of free-tissue transfer. J Reconstr Microsurg 1996 July; 12(5): 283-290.

Rahimizadeh A, Shelton R, Weinberg H, Sadick N. The development of a Marjolin's cancer in a Human Imunodeficiency Virus-positive hemophilic man and review of the literature. Dermatol Surg 1997; 23: 560.

Hirigoyen MB, Blackwell K, Zhang W, Silver L, Weinberg H. Continuous tissue oxygen tension measurement as a monitor of free flap viability. Pl Reconstr Surg 1997 Mar; 99(3): 763-773.

Reis ED, Roque M, Zhang WX, Fallon JT, Weinberg H, Badimon JJ, Taubman MB. Neointimal hyperplasia after femoral artery transluminal injury in C57BL/6 and FVB mice. Surg Forum 1998;: 303-49.

Taub P, Marmur JD, Zhang WX, Senderoff D, Nhat PD, Phelps R, Urken ML, Silver L, Weinberg H. Locally administered vascular endothelial growth factor (VEGF) cDNA increases survival of ischemic experimental skin flaps. Plast Reconstr Surg 1998; 102: 2033.

Taub PJ, Marmur J, Zhang W, Senderoff D, Urken ML, Weinberg H, Silver L. Effect of Time On Viability of Ischemic Skin Flaps Treated with Endothelial Growth Factor (VEGF) with DNA. J Reconstr Microsurg 1998; 14: 387-390.

Vickery CV, Urken M, Weinberg H, Buchbinder D, Biller HF. Advancements in head and neck reconstruction; microvascular free tissue transfer - Parts 1, 2. Surg Rounds 1998; 21: 27, 90.

Li QF, Zhang WX, Reis ED, Taub PJ, Weinberg H. Human recombinant vascular growth endothelial factor (VEGF) accelerates maturation of rat tail artery prefabricated flap. Surg Forum 1999; 50: 586.

Weinberg H, Chun JK, Silver L. Plastic surgical perspectives on vascular endothelial growth factor (VEGF) as gene therapy for angiogenesis. Plast Reconstr Surg 2000; 105: 1034.

Li QF, Reis ED, Zhang WX, Silver L, Fallon JY, Weinberg H. Accelerated flap prefabrication with vascular endothelial growth factor. J Reconstr Microsurg 2000; 16: 45.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr.Weinberg is not currently required to report Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

1050 Park Avenue
New York, NY 10028

Tel: 917-492-4200
Fax: 917-492-4300
Get Directions

Office Hours:
  • Monday 9:00am - 6:00pm
  • Tuesday 9:00am - 5:00pm
  • Wednesday 9:00am - 5:00pm
  • Thursday 9:00am - 6:00pm
  • Friday 9:00am - 5:00pm
Languages:
  • Hebrew
Payment Methods
  • Master Card
  • Visa
  • American Express
  • Personal Check